Agios Pharma (AGIO) Tops Q3 EPS by 3c; Reports Cash and Cash Equivalents of $1.4B
Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.56), $0.03 better than the analyst estimate of ($1.59).
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.